Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27088820 | 0.83 | PAOX (0.36) | PAOXKDM4ECYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL1831104 | 0.83 | PAOX (0.45) | PAOXKDM4ECHRM1CYP2C9CYP2C19 | |
| SCHEMBL11439604 | 0.82 | PAOX (0.52) | PAOXKDM4ECHRM1CYP2C9CYP2C19 | |
| SCHEMBL8599501 | 0.81 | CYP2C9 (0.56) | PAOXKDM4ECHRM1CYP2C9CYP2C19 | |
| SCHEMBL1833032 | 0.81 | PAOX (0.47) | PAOXKDM4ECHRM1CYP2C9CYP2C19 | |
| SCHEMBL1831880 | 0.80 | CHRM1 (0.35) | PAOXCHRM1CYP2C19ALDH1A1MEN1 | |
| SCHEMBL1833619 | 0.79 | PAOX (0.34) | PAOXKDM4ECHRM1CYP2C9CYP2C19 | |
| SCHEMBL10614292 | 0.79 | PAOX (0.42) | PAOXKDM4ECYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL1830852 | 0.78 | ALDH1A1 (0.36) | PAOXKDM4ECHRM1ALDH1A1MEN1 | |
| SCHEMBL31370382 | 0.77 | CTH (0.34) | PAOXKDM4ECHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230146675-A1 | PYRIMIDO[5,4-d]PYRIMIDINE DERIVATIVES AS ENT INHIBITORS FOR THE TREATMENT OF CANCERS, AND COMBINATION THEREOF WITH ADENOSINE RECEPTOR ANTAGONISTS | iTeos Belgium SA (BE) | 2023-05-11 | — | — | US | disclosed |
| EP-2323145-A1 | Electrolytic solution for electrolytic capacitor and electrolytic capacitor as well as method for preparing an organic onium tetrafluoroaluminate | MITSUBISHI CHEMICAL CORPORATION (JP) | 2011-05-18 | — | — | EP | disclosed |
| EP-2323144-A1 | Electrolytic capacitor | MITSUBISHI CHEMICAL CORPORATION (JP) | 2011-05-18 | — | — | EP | disclosed |
| CN-100466122-C | Electrolytic solution for electrolytic capacitor, and method for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEM CORP (JP) | 2009-03-04 | — | — | CN | disclosed |
| US-7397651-B2 | Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEMICAL CORPORATION (JP) | 2008-07-08 | — | — | US | disclosed |
| US-7295424-B2 | Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-11-13 | — | — | US | disclosed |
| US-20070188977-A1 | ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20070188979-A1 | ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| US-7227738-B2 | Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-06-05 | — | — | US | disclosed |
| US-20060007629-A1 | Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-01-12 | — | — | US | disclosed |
| CN-1708817-A | Electrolytic solution for electrolytic capacitor, and method for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEM CORP (JP) | 2005-12-14 | — | — | CN | disclosed |
| EP-1564768-A1 | ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM | Mitsubishi Chemical Corporation (JP) | 2005-08-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230146675-A1 | PYRIMIDO[5,4-d]PYRIMIDINE DERIVATIVES AS ENT INHIBITORS FOR THE TREATMENT OF CANCERS, AND COMBINATION THEREOF WITH ADENOSINE RECEPTOR ANTAGONISTS | ENTPD5, ENTPD1, SLC29A1 | PAOX 2825/4885KDM4E 2925/4885CHRM1 4483/4885 |
| US-20070188977-A1 | ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM | AFF2, CACNA2D2, AFF4 | PAOX 3467/4885KDM4E 1659/4885CHRM1 1644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.